rs2990510

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001994.3(F13B):​c.1556-649A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.259 in 151,994 control chromosomes in the GnomAD database, including 5,507 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.26 ( 5507 hom., cov: 32)

Consequence

F13B
NM_001994.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.308

Publications

19 publications found
Variant links:
Genes affected
F13B (HGNC:3534): (coagulation factor XIII B chain) This gene encodes coagulation factor XIII B subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as a plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon activation by the cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq, Jul 2008]
F13B Gene-Disease associations (from GenCC):
  • factor XIII, b subunit, deficiency of
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • congenital factor XIII deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.312 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
F13BNM_001994.3 linkc.1556-649A>C intron_variant Intron 9 of 11 ENST00000367412.2 NP_001985.2 P05160

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
F13BENST00000367412.2 linkc.1556-649A>C intron_variant Intron 9 of 11 1 NM_001994.3 ENSP00000356382.2 P05160
F13BENST00000649282.1 linkc.311-649A>C intron_variant Intron 2 of 4 ENSP00000497116.1 A0A3B3IS66

Frequencies

GnomAD3 genomes
AF:
0.259
AC:
39350
AN:
151876
Hom.:
5501
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.158
Gnomad AMI
AF:
0.495
Gnomad AMR
AF:
0.255
Gnomad ASJ
AF:
0.300
Gnomad EAS
AF:
0.130
Gnomad SAS
AF:
0.297
Gnomad FIN
AF:
0.306
Gnomad MID
AF:
0.310
Gnomad NFE
AF:
0.316
Gnomad OTH
AF:
0.259
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.259
AC:
39364
AN:
151994
Hom.:
5507
Cov.:
32
AF XY:
0.257
AC XY:
19073
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.158
AC:
6557
AN:
41496
American (AMR)
AF:
0.255
AC:
3876
AN:
15200
Ashkenazi Jewish (ASJ)
AF:
0.300
AC:
1040
AN:
3468
East Asian (EAS)
AF:
0.130
AC:
669
AN:
5164
South Asian (SAS)
AF:
0.297
AC:
1431
AN:
4826
European-Finnish (FIN)
AF:
0.306
AC:
3243
AN:
10582
Middle Eastern (MID)
AF:
0.310
AC:
91
AN:
294
European-Non Finnish (NFE)
AF:
0.316
AC:
21452
AN:
67948
Other (OTH)
AF:
0.264
AC:
555
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1469
2939
4408
5878
7347
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
420
840
1260
1680
2100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.298
Hom.:
12694
Bravo
AF:
0.251
Asia WGS
AF:
0.222
AC:
770
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
5.9
DANN
Benign
0.74
PhyloP100
0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2990510; hg19: chr1-197020658; API